Global Digital Brain Therapy Market Overview:
The global digital brain therapy market is expected to grow during the forecasted year due to the increasing brain disorders, brain injuries and especially depression and anxiety problems. The digital brain therapy adjusts the physical therapy program based on one's pain level, performance, and recovery goals. In this therapy, if an individual using rehabilitative brain therapy is struggling with a particular exercise in their program, they are automatically given an alternative exercise that can help strengthen the foundation of skills needed to progress, without frustration or confusion. Digital brain therapy is designed to help people improve the specific functional capabilities needed for daily living. Some of the key players profiled in the study are Abbott Laboratories (United States), Total Brain (United States), Cogstate Ltd. (Australia), Emotiv Inc. (United States), Lumos Labs, Inc. (United States), NeuroSky, Inc. (United States), Flow Neuroscience (Sweden) and Magstim (United Kingdom).
On the basis of geography, the market of Digital Brain Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Devices (Sensors, Wearables, Monitors) will boost the Digital Brain Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapy, the sub-segment i.e. Electroconvulsive Therapy (ECT) will boost the Digital Brain Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Soldiers will boost the Digital Brain Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Number of Brain Disorders in People
- The Need to Diagnose and Treat Severe Depression Accompanied by Psychosis Which Does not Respond to Medication
- Growing Number of Brain Injuries Happening Due to Accidents
- The Adoption of Cloud-based Treatment in Digital Brain Therapy
- The Advent of AR and VR Technology in Digital Brain Therapy
- Side Effects Like Headache, Upset Stomach, Muscle Aches, Memory Loss Associated with Digital Brain Therapy
- Awareness about Brain Health whether Physical or Psychological
- Rising Neurological Segment of the Healthcare Industry
- Spendings on Healthcare Industry will Boost the Digital Brain Therapy Market
- Technical Issues with Wearable Handbands and Sensors Used in Digital Brain Therapy
Major Market Developments:
On 24th January 2020, Abbott Laboratories announced the approval of the US Food and Drug Administration (FDA) for a new expanded indication for the company's infinity Deep Brain Stimulation (DBS) system to include the targeting of an area of the brain called the internal globus pallidus (GPi). It is targeted to improve the symptoms of Parkinson's disease not adequately controlled by medication. It is the world's first and only DBS system operating in these indications on an iOS software platform with Bluetooth wireless technology. Clinicians can streamline the programming process with an iPad mini device using Abbott's new Infirmity Programming feature to become more efficient in their practice and achieve optimal outcomes with directional leads. Patients can discreetly manage their symptoms with their Infinity DBS System iPod touch controller.
"According to the FDA, it is not intended to be a first-line treatment, even for patients with severe depression. And, despite FDA approval, VNS remains an infrequently used because results of early studies testing its effectiveness for major depression were mixed. But a newer study, which pooled together findings from only controlled clinical trials, found that 32% of depressed people responded to VSN and 14% had full remission of symptoms after being treated for nearly 2 years."
Digital Brain Therapy Devices Manufacturers, Digital Brain Therapy Service Providers, Digital Brain Therapy Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies, Hospitals and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Digital Brain Therapy market on the basis of product  , application [Hospitals, Clinics and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Digital Brain Therapy market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Digital Brain Therapy industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Digital Brain Therapy market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.